Trial Supports Hypofractionated Radiotherapy in Uterine Cancer
A pilot study found that delivery of approximately the same dose over just 2.5 weeks, known as hypofractionation, had good short-term toxicity outcomes.
Source: medscape.com
Stay updated with breaking news from Vonetta Williams. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A pilot study found that delivery of approximately the same dose over just 2.5 weeks, known as hypofractionation, had good short-term toxicity outcomes.
It isn’t yet clear if the protocol will be as effective as the standard course, and long-term side effects may still be an issue.